Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health Dementia Alzheimer's Disease

Focused ultrasound shows promise in treating Alzheimer’s by reducing amyloid plaques

by Eric W. Dolan
January 15, 2025
in Alzheimer's Disease
(Photo credit: Adobe Stock)

(Photo credit: Adobe Stock)

Share on TwitterShare on Facebook
Follow PsyPost on Google News

A new study published in the Journal of Neurosurgery highlights the potential of focused ultrasound technology in treating Alzheimer’s disease. The clinical trial demonstrated that repetitive opening of the blood-brain barrier using focused ultrasound reduced amyloid plaques—protein buildups linked to Alzheimer’s—without using Alzheimer’s medications. In addition to clearing plaques, the treatment led to improvements in neuropsychiatric symptoms, such as anxiety and irritability, for the majority of participants, showing promise as a new approach to managing this debilitating condition.

Jin Woo Chang, a neurosurgeon at Korea University Anam Hospital, led the study alongside neurologists from Yonsei University. The researchers aimed to explore the potential of focused ultrasound to tackle Alzheimer’s more effectively.

Alzheimer’s disease, a progressive neurodegenerative disorder, is marked by cognitive decline and the accumulation of harmful amyloid-beta plaques in the brain. These plaques have been a primary target for therapies, but existing treatments often struggle to effectively deliver drugs to the brain due to the protective blood-brain barrier. Focused ultrasound offers a way to temporarily open this barrier, enabling access to deeper brain regions.

The study enrolled six women aged 50 to 85 diagnosed with Alzheimer’s. Participants underwent three sessions of blood-brain barrier opening at two-month intervals using the ExAblate Neuro 220 kHz low-intensity focused ultrasound system. A microbubble agent, DEFINITY®, was injected intravenously during the procedure to enhance the ultrasound’s effect. This treatment targeted both frontal lobes, focusing on areas of the brain commonly affected by Alzheimer’s. Before and after the sessions, researchers used advanced imaging techniques and neuropsychiatric assessments to evaluate changes in amyloid levels and mental health symptoms.

The study achieved a significant milestone by safely opening a blood-brain barrier volume of 43.1 cubic centimeters—double the volume of previous trials. Importantly, this approach reduced amyloid plaques in four of the six participants. Neuropsychiatric symptoms, measured through the Caregiver-Administered Neuropsychiatric Inventory, improved in five participants, with reductions in issues like agitation, delusions, and anxiety. No serious side effects were reported, and participants tolerated the procedure well, despite its duration and the requirement to remain still.

Chang and his colleagues emphasized that the study’s design isolated the effects of the blood-brain barrier opening alone, without combining it with medications. This allowed them to assess whether focused ultrasound could independently reduce amyloid plaques and improve symptoms. The findings suggest that even without drugs, clearing plaques may positively impact Alzheimer’s symptoms, particularly those related to behavior and mood.

“We developed this protocol to provide optimal benefit and to test the technology in larger regions of the brain that are affected by Alzheimer’s disease,” said Chang. “This study begins to provide a more complete understanding of the effects of blood-brain barrier opening alone. It will serve as the basis for future trials comparing any potential benefit of adding drug delivery the affected areas of the brain.”

The research was funded by the Focused Ultrasound Foundation.

“This study is critical to the field as a whole,” said Foundation Chairman Neal F. Kassell, MD. “Knowing what happens with blood-brain barrier opening in the absence of drugs in patients with Alzheimer’s disease adds a tremendous amount of knowledge to the field and lays the groundwork for further exploration with multiple focused ultrasound mechanisms of action. Focused ultrasound is a new technology that is now being explored in patients with Alzheimer’s disease, a field that has remained stagnant in terms of therapeutic options over the past several decades.”

However, the study’s small sample size limits the generalizability of its results. With only six participants, further research with larger groups is needed to confirm these findings. Additionally, while neuropsychiatric symptoms improved, the study did not observe significant cognitive improvements, such as better memory or problem-solving abilities. This may be because the treatment focused solely on the frontal lobes, while regions like the hippocampus—critical for memory—were not targeted.

Looking ahead, researchers plan to build on these results by conducting larger trials. Future studies will explore the effects of opening even larger brain regions and combining focused ultrasound with Alzheimer’s medications to enhance treatment outcomes. These efforts aim to refine the technique and maximize its potential benefits for patients at various stages of the disease.

The study, “Repetitive and extensive focused ultrasound–mediated bilateral frontal blood-brain barrier opening for Alzheimer’s disease,” was authored by Byoung Seok Ye, Kyung Won Chang, Sungwoo Kang, Seun Jeon, and Jin Woo Chang.

TweetSendScanShareSendPinShareShareShareShareShare

RELATED

New study finds online self-reports may not accurately reflect clinical autism diagnoses
Alzheimer's Disease

Small folds in the brain may hold key insights into Alzheimer’s and aging-related cognitive decline

July 2, 2025

Smaller, shallow brain folds in the posteromedial cortex show greater thinning with age and Alzheimer’s disease, and their structure is closely linked to memory and executive function, suggesting they may be key markers of cognitive decline.

Read moreDetails
Poor sleep may shrink brain regions vulnerable to Alzheimer’s disease, study suggests
Alzheimer's Disease

Poor sleep may shrink brain regions vulnerable to Alzheimer’s disease, study suggests

June 14, 2025

Spending less time in slow wave and REM sleep may accelerate brain atrophy in regions affected early in Alzheimer’s disease, according to new research. The findings support sleep quality as a potential factor in preserving brain health.

Read moreDetails
Neuroscience discoveries: 5 new studies offer unexpected insights into the brain
Alzheimer's Disease

Common sleep aid blocks brain inflammation and tau buildup in Alzheimer’s model

June 13, 2025

Scientists have found that lemborexant not only increased restorative sleep in male mice but also reduced levels of toxic tau and brain inflammation. The findings suggest that targeting the brain’s orexin system may help slow Alzheimer’s progression.

Read moreDetails
Older adults adhering to Mediterranean diet have 11% lower odds of developing dementia, study finds
Alzheimer's Disease

Mediterranean diet appears to weaken the depression–Alzheimer’s connection

June 7, 2025

A new study suggests that the Mediterranean diet may reduce the biological impact of depression on the brain. In older men, depressive symptoms were linked to higher Alzheimer’s biomarkers—except in those with strong adherence to a Mediterranean-style diet.

Read moreDetails
Beta blockers: how these common heart medications may reduce the risk of violence
Alzheimer's Disease

Long-term SSRI use linked to reduced Alzheimer’s pathology but mixed effects on cognition

May 29, 2025

A new study suggests long-term SSRI use may reduce markers of Alzheimer’s disease and restore brain function in affected regions, but the impact on cognitive performance remains mixed depending on how it’s measured.

Read moreDetails
Cannabidiol shows promise for treating Alzheimer’s in mice by targeting brain hyperactivity
Alzheimer's Disease

Cannabidiol shows promise for treating Alzheimer’s in mice by targeting brain hyperactivity

May 26, 2025

In a study using an Alzheimer’s disease mouse model, researchers found that cannabidiol reduced memory loss and brain abnormalities. The compound worked by enhancing the function of glycine receptors, which help regulate neuronal activity in the brain's memory center.

Read moreDetails
A common childhood virus could be silently fueling Alzheimer’s disease in old age
Alzheimer's Disease

A common childhood virus could be silently fueling Alzheimer’s disease in old age

May 25, 2025

A virus best known for causing cold sores may dramatically increase the risk of Alzheimer’s in people with a specific gene variant. New evidence suggests herpes reactivation in the brain may trigger the destructive changes seen in the disease.

Read moreDetails
Scientists find 16 new Alzheimer’s-linked genes using multi-ancestry genome data
Alzheimer's Disease

Scientists find 16 new Alzheimer’s-linked genes using multi-ancestry genome data

May 23, 2025

A groundbreaking genome-wide analysis has revealed new genetic regions associated with Alzheimer’s disease—many missed in past studies focused on European populations. The findings point to underexplored biological pathways and highlight the value of studying diverse ancestry groups.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

New study finds link between sexism and denial of male victimhood in relationships

Viral AI-images highlight how Trump engages in “victimcould,” scholar argues

Breakfast habits are associated with depressive symptoms, study finds

Neuroscientists detect decodable imagery signals in brains of people with aphantasia

Loneliness predicts an increase in TV viewing for older women, but not for men

Othello syndrome: Woman’s rare stroke leads to psychotic delusions of infidelity

How to protect your mental health from a passive-aggressive narcissist

Dark personality traits linked to generative AI use among art students

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy